Publication:
Transmitted drug resistance and antiretroviral treatment outcomes in non-subtype B HIV-1-infected patients in south east asia

Simple item page
dc.contributor.authorPraphan Phanuphaken_US
dc.contributor.authorSunee Sirivichayakulen_US
dc.contributor.authorAwachana Jiamsakulen_US
dc.contributor.authorSomnuek Sungkanuparphen_US
dc.contributor.authorNagalingeswaran Kumarasamyen_US
dc.contributor.authorMan Po Leeen_US
dc.contributor.authorThira Sirisanthanaen_US
dc.contributor.authorPacharee Kantipongen_US
dc.contributor.authorChristopher Leeen_US
dc.contributor.authorAdeeba Kamarulzamanen_US
dc.contributor.authorMahiran Mustafaen_US
dc.contributor.authorRossana Ditangcoen_US
dc.contributor.authorTuti Meratien_US
dc.contributor.authorWinai Ratanasuwanen_US
dc.contributor.authorThida Singtorojen_US
dc.contributor.authorRami Kantoren_US
dc.contributor.otherThe HIV Netherlands Australia Thailand Research Collaborationen_US
dc.contributor.otherChulalongkorn Universityen_US
dc.contributor.otherUniversity of New South Wales (UNSW) Australiaen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherYR Gaitonde Centre for AIDS Research and Educationen_US
dc.contributor.otherQueen Elizabeth Hospital Hong Kongen_US
dc.contributor.otherChiang Mai Universityen_US
dc.contributor.otherChiangrai Prachanukroh Hospitalen_US
dc.contributor.otherHospital Sungai Bulohen_US
dc.contributor.otherUniversity of Malayaen_US
dc.contributor.otherHospital Raja Perempuan Zainab IIen_US
dc.contributor.otherGokilaen_US
dc.contributor.otherUniversitas Udayanaen_US
dc.contributor.otheramfAR - The Foundation for AIDS Researchen_US
dc.contributor.otherBrown Universityen_US
dc.date.accessioned2018-11-09T02:37:31Z
dc.date.available2018-11-09T02:37:31Z
dc.date.issued2014-05-01en_US
dc.description.abstractBACKGROUND: We compared treatment outcomes of transmitted drug resistance (TDR) in patients on fully or partially sensitive drug regimens. METHODS: Factors associated with survival and failure were analyzed using Cox proportional hazards and discrete time conditional logistic models. RESULTS: TDR, found in 60 (4.1%) of 1471 Asian treatment-naive patients, was one of the significant predictors of failure. Patients with TDR to >1 drug in their regimen were >3 times as likely to fail compared to no TDR. CONCLUSIONS: TDR was associated with failure in the context of non-fully sensitive regimens. Efforts are needed to incorporate resistance testing into national treatment programs. © 2013 by Lippincott Williams and Wilkins.en_US
dc.identifier.citationJournal of Acquired Immune Deficiency Syndromes. Vol.66, No.1 (2014), 74-79en_US
dc.identifier.doi10.1097/QAI.0000000000000108en_US
dc.identifier.issn10779450en_US
dc.identifier.issn15254135en_US
dc.identifier.other2-s2.0-84898539282en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/34249
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84898539282&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleTransmitted drug resistance and antiretroviral treatment outcomes in non-subtype B HIV-1-infected patients in south east asiaen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84898539282&origin=inwarden_US

Files

Collections

Scopus 2011-2015